About LKH Villach
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Landeskrankenanstalten-Betriebsgesellschaft
2
Arbeitsgemeinschaft medikamentoese Tumortherapie
1
Boehringer Ingelheim
1
ETOP IBCSG Partners Foundation
1
Hoffmann-La Roche
1
IHF GmbH - Institut für Herzinfarktforschung
1
Medical University of Graz
1
Morphotek
1
Otsuka Pharmaceutical Europe Ltd
1
Clinical Trials at LKH Villach
During the past decade, LKH Villach conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
2002-10-01
2003-11-01
Completed
801
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus
2010-02-01
2014-02-01
Completed
193
Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold
2013-11-08
2021-07-06
Completed
3,330
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "LKH Villach" #1 sponsor was "Landeskrankenanstalten-Betriebsgesellschaft" with 2 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LKH Villach"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "European Commission" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Barmherzige Brüder Vienna" with 1 trials as a collaborator and "Centre Hospitalier Régional de la Citadelle" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at LKH Villach
According to Clinical.Site data, the most researched conditions in "LKH Villach" are
"Breast Cancer" (2 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Coronary Artery Stenosis" (1 trials), "Covid19" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "LKH Villach" in a lesser frequency.
Clinical Trials Intervention Types at LKH Villach
Most popular intervention types in "LKH Villach" are "Drug" (6 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "ABSORB Scaffold" (1 trials), "Carboplatin" (1 trials), "Cholecalciferol" (1 trials), "Farletuzumab" (1 trials) and "Farletuzumab-matched placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at LKH Villach
The vast majority of trials in "LKH Villach" are
7 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at LKH Villach
Currently, there are NaN active trials in "LKH Villach".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in LKH Villach,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in LKH Villach, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".